Key facts
- It has raised $1.4M; the latest was Later Stage VC in Sep 2025.
- Notable investors include CAS Star, Hunan Chasing Fund, Guangdong Bawei Bio-technology.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Jipure Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jipure Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jipure Biotechnology
Manufacturer of surfactants intended for the daily chemicals, agriculture, environmental protection and personal care fields. The company's range of products includes soapberry extract, camellia oleifera extract, and other plant-derived surfactants, thereby providing biodegradable, non-toxic alternatives that support sustainable product development.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Beijing, China
- Founded
- 2018
- Employees
- 5
- Website
- gdjingcui.com/
- Ownership
- Privately Held (backing)
Jipure Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jipure Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jipure Biotechnology in its N-PORT filings yet. We sweep new filings monthly.